The Life Sciences Innovative Manufacturing Fund provides capital grants up to £130 million for UK private sector companies investing in manufacturing human medicines, medical diagnostics, and MedTech products. Projects must be UK-based, with capital costs over £8 million, and demonstrate health resilience and economic benefits. The fund supports projects that comply with GMP and Medical Devices Regulations, aiming to strengthen UK health resilience and create high-skilled jobs.
Eligible applicants are UK-registered private sector companies involved in product development or manufacturing of medicines or medical devices. Applicants must provide two years of audited accounts or demonstrate funding availability. Projects must be UK-based capital investments with costs over £8
